The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models

Naiara Martínez-Vélez1,2,3, Marc Garcia-Moure1,2,3, Miguel Marigil1,2,3

  • 1Health Research Institute of Navarra (IDISNA), Pamplona, Navarra, Spain.

Insights

Delta-24-RGD oncolytic virotherapy shows promise for treating pediatric high-grade gliomas (pHGG) and diffuse intrinsic pontine gliomas (DIPGs). This adenovirus therapy is safe and enhances survival by directly attacking tumors and stimulating an immune response.

Area of Science:

  • Oncology
  • Virology
  • Immunology

Background:

  • Pediatric high-grade gliomas (pHGG) and diffuse intrinsic pontine gliomas (DIPGs) are aggressive brain tumors with limited treatment options.
  • Oncolytic virotherapy presents a promising therapeutic strategy for these challenging pediatric cancers.

Purpose of the Study:

  • To evaluate the safety and efficacy of Delta-24-RGD, a replication-competent adenovirus, in preclinical models of pHGG and DIPGs.
  • To investigate the mechanisms underlying the anti-glioma effects of Delta-24-RGD.

Main Methods:

  • Administration of Delta-24-RGD to immunodeficient and immunocompetent mouse models of pHGG and DIPGs.
  • Assessment of tumor growth, survival rates, and immune responses post-treatment.

Main Results:

  • Delta-24-RGD demonstrated a safe profile in mice.
  • Significant increases in survival were observed in both immunodeficient and immunocompetent models.
  • The anti-glioma effect was attributed to both direct oncolysis and virus-induced immune responses.

Conclusions:

  • Delta-24-RGD is a safe and effective oncolytic virus for pediatric high-grade gliomas and DIPGs.
  • The dual mechanism of action (oncolysis and immune stimulation) supports its therapeutic potential.
  • These findings have led to a Phase I/II clinical trial for newly diagnosed DIPG.

Related Concept Videos

The Delta-to-Delta Circuit01:17

The Delta-to-Delta Circuit

In a delta-delta configuration, the source and the load are connected in a delta manner, forming a closed loop that divides the network into three distinct phases. This configuration makes the phase voltages identical to line voltages. Assuming the sources are in positive sequence, the phase voltages can be expressed directly without having a neutral wire.
1.1K
The Y-to-Delta Circuit01:19

The Y-to-Delta Circuit

A balanced wye-to-delta circuit comprises balanced Y-connected voltage sources and delta-connected loads with no neutral line connection.
The initial step in analyzing a wye-to-delta circuit is to assume a positive phase sequence. These phase voltages are then utilized to calculate the line voltages that occur directly across the delta-connected load impedances. Van, Vbn, and Vcn are the phase voltages in wye, and Vab, Vbc, and Vca are the line voltages for a delta circuit. The relation between...
701
The Delta-to-Y Circuit01:16

The Delta-to-Y Circuit

In the delta-wye circuit, the source is delta-connected, while the load is in a wye configuration. This means that the phase voltage of the delta-connected source is equal to the line voltage of the wye-connected load. The connection between two-line currents originates from the delta-connected source. The phase difference in the balanced system allows for calculating one line current given the other, utilizing the positive sequence of phases. In the delta-wye system, the phase currents in the...
857
What are Viruses?00:50

What are Viruses?

Overview
127.9K
Holter Monitor: 24-Hour Monitoring01:23

Holter Monitor: 24-Hour Monitoring

Holter monitoring is a continuous electrocardiography (ECG) recording that tracks the heart's electrical activity over an extended period, generally 24 to 48 hours. This noninvasive diagnostic tool detects irregular heart rhythms that may not be captured during a standard ECG performed in a clinical setting.DeviceThe Holter monitor is a portable, small device connected to several electrodes on the patient's chest. These electrodes detect the heart's electrical signals and transmit them to the...
2.3K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214